Differential changes in the pharmacokinetics of doxorubicin in diethylnitrosamine-induced hepatocarcinoma model rats-Reference-Cited by-同舟云学术

Differential changes in the pharmacokinetics of doxorubicin in diethylnitrosamine-induced hepatocarcinoma model rats

Published:2020-05-13 Issue:10 Volume:50 Page:1251-1257
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Pan Jie¹^ORCID,Lu Yuan²,Zhang Shuai³,Li Yueting²,Sun Jia²,Liu Hua Chunhua⁴,Gong Zipeng²,Huang Jing⁵,Cao Chuang⁵,Wang Yonglin²,Li Yongjun¹,Liu Ting⁶

Affiliation:

1. State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, School of Pharmacy, Guizhou Medical University, Guiyang, China;

2. Key Laboratory of Pharmaceutics of Guizhou Provincial, School of Pharmacy, Guizhou Medical University, Guiyang, China;

3. Department of Interventional Radiology, Guizhou Medical University, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China;

4. School of Pharmacy, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education, Guizhou Medical University, Guiyang, China;

5. School of Pharmacy, Guizhou Medical University, Guiyang, China;

6. Key Laboratory of Pharmaceutics of Guizhou Provincial, State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmacy, Guizhou Medical University, Guiyang, China

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2020.1765049

Reference43 articles.

1. Thiamine potentiates chemoprotective effects of ibuprofen in DEN induced hepatic cancer via alteration of oxidative stress and inflammatory mechanism

2. Hepatocellular carcinoma in Asia: Prevention strategy and planning

3. P-glycoprotein, multidrug resistance and tumor progression

4. Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats

5. Encapsulation of P-glycoprotein inhibitors by polymeric micelles can reduce their pharmacokinetic interactions with doxorubicin

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aidi injection altered the activity of CYP2D4, CYP1A2, CYP2C19, CYP3A2, CYP2E1 and CYP2C11 in normal and diethylnitrosamine-induced hepatocellular carcinoma in rats;Journal of Ethnopharmacology;2022-03

2. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects;Drug Discovery Today;2022-02

3. Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma;BMC Pharmacology and Toxicology;2021-09-06

4. Carbonyl reduction pathway in hepatic in vitro metabolism of anthracyclines: Impact of structure on biotransformation rate;Toxicology Letters;2021-05